Novo Nordisk shares sink after Alzheimer's drug trial fails | REUTERS
Автор: Reuters
Загружено: 2025-11-24
Просмотров: 824
Описание:
Novo Nordisk reported that its Rybelsus oral semaglutide did not meet the main goal in late-stage trials for Alzheimer's patients, triggering a sharp selloff and a multi-year share price low.
#News #Reuters #Newsfeed #novonordisk #alzheimers #medicine #pharmaceuticals
Read the story here: https://reut.rs/4rggmFy
👉 Subscribe: http://smarturl.it/reuterssubscribe
Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: / reuters
Follow Reuters on Twitter: / reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: